Efficacy of transarterial chemoembolization compared with radiofrequency ablation for the treatment of recurrent hepatocellular carcinoma after radiofrequency ablation

References

• El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557–2576.
   PubMed Web of Science ®Google Scholar
• Simonetti RG, Cammà C, Fiorello F, et al. Hepatocellular carcinoma. A worldwide problem and the major risk factors. Dig Dis Sci. 1991;36:962–972.
   PubMed Web of Science ®Google Scholar
• EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908–943.
   PubMed Web of Science ®Google Scholar
• Chu KK, Cheung TT. Update in management of hepatocellular carcinoma in Eastern population. WJH. 2015;7:1562–1571.
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020–1022.
   PubMed Web of Science ®Google Scholar
• Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67:358–380.
   PubMed Web of Science ®Google Scholar
• Hsueh KC, Lee TY, Kor CT, et al. The role of liver transplantation or resection for patients with early hepatocellular carcinoma. Tumour Biol. 2016;37:4193–4201.
   PubMedGoogle Scholar
• Kaido T, Morita S, Tanaka S, et al. Long-term outcomes of hepatic resection versus living donor liver transplantation for hepatocellular carcinoma: a propensity score-matching study. Dis Markers. 2015;2015:1.
   Google Scholar
• Xu XS, Liu C, Qu K, et al. Liver transplantation versus liver resection for hepatocellular carcinoma: a meta-analysis. Hepatobiliary Pancreat Dis Int. 2014;13:234–241.
   PubMed Web of Science ®Google Scholar
• Lee HS, Choi GH, Joo DJ, et al. The clinical behavior of transplantable recurrent hepatocellular carcinoma after curative resection: implications for salvage liver transplantation. Ann Surg Oncol. 2014;21:2717–2724.
   PubMed Web of Science ®Google Scholar
• Lee KK, Kim DG, Moon IS, et al. Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma. J Surg Oncol. 2010;101:47–53.
   PubMed Web of Science ®Google Scholar
• Guo W, He X, Li Z, et al. Combination of Transarterial Chemoembolization (TACE) and Radiofrequency Ablation (RFA) vs. Surgical Resection (SR) on Survival Outcome of Early Hepatocellular Carcinoma: A Meta-Analysis. Hepatogastroenterology. 2015;62:710–714.
   PubMedGoogle Scholar
• Hocquelet A, Balageas P, Laurent C, et al. Radiofrequency ablation versus surgical resection for hepatocellular carcinoma within the Milan criteria: A study of 281 Western patients. Int J Hyperthermia. 2015;31:749–757.
   PubMed Web of Science ®Google Scholar
• Bu X, Ge Z, Ma J, et al. Long-term efficacy of radiofrequency ablation compared to surgical resection for the treatment of small hepatocellular carcinoma. J BUON. 2015;20:548–554.
   PubMed Web of Science ®Google Scholar
• Fu C, Liu N, Deng Q, et al. Radiofrequency ablation vs. surgical resection on the treatment of patients with small hepatocellular carcinoma: a system review and meta-analysis of five randomized controlled trials. Hepatogastroenterology. 2014;61:1722–1729.
   PubMed Web of Science ®Google Scholar
• Xu Q, Kobayashi S, Ye X, et al. Comparison of hepatic resection and radiofrequency ablation for small hepatocellular carcinoma: a meta-analysis of 16,103 patients. Sci Rep. 2015;4:7252.
   Web of Science ®Google Scholar
• Givehchi S, Wong YH, Yeong CH, et al. Optimal approach for complete liver tumor ablation using radiofrequency ablation: a simulation study. Minim Invasiv Ther Allied Technol. 2018;27:81–89.
   PubMed Web of Science ®Google Scholar
• Lin SM, Lin CJ, Lin CC, et al. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut. 2005;54:1151–1156.
   PubMed Web of Science ®Google Scholar
• Yamashita S, Aoki T, Inoue Y, et al. Outcome of salvage hepatic resection for recurrent hepatocellular carcinoma after radiofrequency ablation therapy. Surgery. 2015;157:463–472.
   PubMed Web of Science ®Google Scholar
• Chan AC, Chan SC, Chok KS, et al. Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation. Liver Transpl. 2013;19:411–419.
   PubMed Web of Science ®Google Scholar
• Eisele RM, Chopra SS, Lock JF, et al. Treatment of recurrent hepatocellular carcinoma confined to the liver with repeated resection and radiofrequency ablation: a single center experience. Technol Health Care. 2013;21:9–18.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Real MI, Montaña X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 2002;359:1734–1739.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology. 2003;37:429–442.
   PubMed Web of Science ®Google Scholar
• Hu HT, Kim JH, Lee LS, et al. Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort. J Vasc Interv Radiol. 2011;22:917–923.
   PubMed Web of Science ®Google Scholar
• Gnutzmann D, Kortes N, Sumkauskaite M, et al. Transvascular therapy of hepatocellular Carcinoma (HCC), status and developments. Minim Invasiv Ther Allied Technol. 2018;27:69–80.
   PubMed Web of Science ®Google Scholar
• Lee HS, Kim KM, Yoon JH, et al. Therapeutic efficacy of transcatheter arterial chemoembolization as compared with hepatic resection in hepatocellular carcinoma patients with compensated liver function in a hepatitis B virus-endemic area: a prospective cohort study. JCO. 2002;20:4459–4465.
   PubMed Web of Science ®Google Scholar
• Chen R, Gan Y, Ge N, et al. Transarterial chemoembolization versus radiofrequency ablation for recurrent hepatocellular carcinoma after resection within barcelona clinic liver cancer stage 0/A: A Retrospective Comparative Study. J Vasc Interv Radiol. 2016;27:1829–1836.
   PubMed Web of Science ®Google Scholar
• Kim HC, Suk KT, Kim DJ, et al. Transarterial chemoembolization in Barcelona Clinic Liver Cancer Stage 0/A hepatocellular carcinoma. WJG. 2014;20:745–754.
   PubMed Web of Science ®Google Scholar
• Xie X, Jiang C, Peng Z, et al. Local recurrence after radiofrequency ablation of hepatocellular carcinoma: treatment choice and outcome. J Gastrointest Surg. 2015;19:1466–1475.
   PubMed Web of Science ®Google Scholar
• Sato Y, Watanabe H, Sone M, et al. Tumor response evaluation criteria for HCC (hepatocellular carcinoma) treated using TACE (transcatheter arterial chemoembolization): RECIST (response evaluation criteria in solid tumors) version 1.1 and mRECIST (modified RECIST): JIVROSG-0602. Ups J Med Sci. 2013;118:16–22.
   PubMed Web of Science ®Google Scholar
• Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis. 2010;30:052–060.
   PubMed Web of Science ®Google Scholar
• Koh PS, Chan AC, Cheung TT, et al. Efficacy of radiofrequency ablation compared with transarterial chemoembolization for the treatment of recurrent hepatocellular carcinoma: a comparative survival analysis. HPB (Oxford). 2016;18:72–78.
   PubMed Web of Science ®Google Scholar
• Peng Z, Wei M, Chen S, et al. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study. Eur Radiol. 2018;28:3522–3531.
   PubMed Web of Science ®Google Scholar
• Mulier S, Ni Y, Jamart J, et al. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg. 2005;242:158–171.
   PubMed Web of Science ®Google Scholar
• Ruzzenente A, Manzoni GD, Molfetta M, et al. Rapid progression of hepatocellular carcinoma after Radiofrequency Ablation. WJG. 2004;10:1137–1140.
   PubMed Web of Science ®Google Scholar
• Tezuka M, Hayashi K, Okada Y, et al. Therapeutic results of computed-tomography-guided transcatheter arterial chemoembolization for local recurrence of hepatocellular carcinoma after initial transcatheter arterial chemoembolization: the results of 85 recurrent tumors in 35 patients. Dig Dis Sci. 2009;54:661–669.
   PubMed Web of Science ®Google Scholar